FDA approves gene-editing treatment for sickle cell disease

Sickle cell disease affects approximately 100,000 people in the U.S., predominantly people of color.

You may also be interested in

July 27, 2024

July 27, 2024

1501 State St.
East St Louis, IL 62205
(618) 271-0468

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec.

Get our Weekly recap with the latest news, articles and resources.

Cookie policy

We use our own and third party cookies to allow us to understand how the site is used and to support our marketing campaigns.